Search results
Results From The WOW.Com Content Network
Cognitive behavioral therapy for insomnia (CBT-I) is a therapy technique for treating insomnia without (or alongside) medications. CBT-I aims to improve sleep habits and behaviors by identifying and changing thoughts and behaviors that prevent a person from sleeping well.
In medicine, insomnia is measured using the Athens insomnia scale. It was introduced in the year 2000 by a group of researchers [ 1 ] from Athens, Greece to assess the insomnia symptoms in patients with sleep disorders.
Sleep hygiene is a behavioral and environmental practice [2] developed in the late 1970s as a method to help people with mild to moderate insomnia. [2] Clinicians assess the sleep hygiene of people with insomnia and other conditions, such as depression, and offer recommendations based on the assessment.
The concept of the word insomnia has two distinct possibilities: insomnia disorder (ID) or insomnia symptoms, and many abstracts of randomized controlled trials and systematic reviews often underreport on which of these two possibilities the word refers to. [13] Insomnia can occur independently or as a result of another problem. [2]
Consisting of 19 items, the PSQI measures several different aspects of sleep, offering seven component scores and one composite score. The component scores consist of subjective sleep quality, sleep latency (i.e., how long it takes to fall asleep), sleep duration, habitual sleep efficiency (i.e., the percentage of time in bed that one is asleep), sleep disturbances, use of sleeping medication ...
A Journal of Insomnia (French: Journal d'une insomnie collective) is a 2013 web documentary about insomnia, produced by Hugues Sweeney and created by Bruno Choiniere, Philippe Lambert, Thibaut Duverneix and Guillaume Braun for the National Film Board of Canada (NFB).
Zolpidem, sold under the brand name Ambien among others, is a medication primarily used for the short-term treatment of sleeping problems. [11] [16] Guidelines recommend that it be used only after cognitive behavioral therapy for insomnia and after behavioral changes, such as sleep hygiene, have been tried.
Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, in adults. [2] [6] At a dose of 15 to 20 mg and in terms of treatment–placebo difference, it reduces time to sleep onset by up to 10 minutes, reduces time awake after sleep onset by about 15 to 30 minutes, and increases total sleep time by about 10 to 20 minutes. [2]